Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML (MPDMDSBMT)
This study has been terminated.
( Closed due to competing protocols )
Study NCT00069992
Information provided by Baylor College of Medicine
First Received on October 3, 2003.
Last Updated on October 5, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
